[go: up one dir, main page]

Meyers et al., 1980 - Google Patents

Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after marrow transplantation

Meyers et al., 1980

Document ID
10197037484686056863
Author
Meyers J
McGuffin R
Neiman P
Singer J
Thomas E
Publication year
Publication venue
Journal of Infectious Diseases

External Links

Snippet

Eight recipients of marrow transplants with cytomegalovirus (CMV) pneumonia diagnosed by open lung biopsy were treated with doses of human leukocyte interferon of 2× 104-6.4× 105 units/kg per day to evaluate its toxicity after marrow transplant and its effectiveness …
Continue reading at academic.oup.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
    • A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Meyers et al. Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after marrow transplantation
HERSMAN et al. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation
Wade et al. Treatment of cytomegalovirus pneumonia with high-dose acyclovir
Hirsch et al. Cellular immune responses during complicated and uncomplicated measles virus infections of man
Koduri et al. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin—a report of eight patients
Sullivan et al. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.
SARAL et al. Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia: a randomized, double-blind, placebo-controlled study
Reed et al. Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients: a randomized, placebo-controlled trial
Ching et al. Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody
Geerinck et al. A case of human orf in an immunocompromised patient treated successfully with cidofovir cream
Krieger et al. Fertility parameters in men infected with human immunodeficiency virus
Purtilo et al. Epstein-Barr virus infections in the X-linked recessive lymphoproliferative syndrome
Prooijen et al. Prevention of primary transfusion‐associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high‐affinity filters
JPH03503170A (en) Virus inactivated blood products and methods
Steinman et al. Acute interstitial nephritis and iritis: Renal-ocular syndrome
Norrby et al. Treatment of toxoplasmosis with trimethoprim-sulphamethoxazole
Burd et al. Human herpesvirus-6-associated suppression of growth factor-induced macrophage maturation in human bone marrow cultures
Chou et al. Alpha-interferon administration in cytomegalovirus retinitis
Ideström et al. Interferon therapy in multiple myeloma
Townsend et al. Zidovudine for the treatment of HIV-negative patients with psoriasis: a pilot study
Rytel et al. Impaired production of interferon in lymphocytes from immunosuppressed patients
Meyers et al. The use of acyclovir for cytomegalovirus infections in the immunocompromised host
Messina et al. Natural killer cell function and interferon generation in patients with primary immunodeficiencies
McGuffin et al. Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro
Meyers et al. Recombinant leukocyte A interferon for the treatment of serious viral infections after marrow transplant: a phase I study